|Reference : Surgical intervention after transvaginal Prolift mesh repair: retrospective single-cente...|
|Scientific journals : Article|
|Human health sciences : Reproductive medicine (gynecology, andrology, obstetrics)|
|Surgical intervention after transvaginal Prolift mesh repair: retrospective single-center study including 524 patients with 3 years' median follow-up|
|DE LANDSHEERE, Laurent [Centre Hospitalier Universitaire de Liège - CHU > > Gynécologie-Obstétrique CHR >]|
|Ismail, Sharif [ > > ]|
|Lucot, Jean-Philippe [ > > ]|
|Deken, Valérie [ > > ]|
|Foidart, Jean-Michel [Université de Liège - ULg > Département des sciences cliniques > Gynécologie - Obstétrique >]|
|Cosson, Michel [ > > ]|
|American Journal of Obstetrics and Gynecology|
|Yes (verified by ORBi)|
|[en] complications ; pelvic organ prolapse ; polypropylene mesh ; reoperation ; transvaginal mesh ; vaginal surgery|
The aim of this study was to explore the nature and rate of surgical intervention after transvaginal Prolift mesh repair for pelvic organ prolapse.
This was a retrospective study of all patients who underwent Prolift mesh repair between January 2005 and January 2009. Patient data were obtained from medical records, and patients were telephoned to check if they had surgery in other hospitals.
A total of 600 consecutive patients were identified. Of these, 524 patients (87.3%) were included in the study, with a median follow-up duration of 38 months (range, 15–63). Global reoperation rate was 11.6%. Indications of intervention were surgery for urinary incontinence (6.9%), mesh-related complications (3.6%), or prolapse recurrence (3%).
The global reoperation rate after transvaginal Prolift mesh repair was 11.6%, with urinary incontinence surgery being the most common indication. Rates of mesh complications and prolapse recurrence are relatively low in an experienced team.
|File(s) associated to this reference|
All documents in ORBi are protected by a user license.